These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 22672904)
1. Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis. Li W; Tai Y; Zhou J; Gu W; Bai Z; Zhou T; Zhong Z; McCue PA; Sang N; Ji JY; Kong B; Jiang J; Wang C Cell Cycle; 2012 Jun; 11(12):2348-58. PubMed ID: 22672904 [TBL] [Abstract][Full Text] [Related]
2. Sterol regulatory element-binding protein 1 is required for ovarian tumor growth. Nie LY; Lu QT; Li WH; Yang N; Dongol S; Zhang X; Jiang J Oncol Rep; 2013 Sep; 30(3):1346-54. PubMed ID: 23818099 [TBL] [Abstract][Full Text] [Related]
3. SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis. Lin L; Zheng X; Qiu C; Dongol S; Lv Q; Jiang J; Kong B; Wang C Oncol Rep; 2014 Dec; 32(6):2831-5. PubMed ID: 25270091 [TBL] [Abstract][Full Text] [Related]
4. BF175 inhibits endometrial carcinoma through SREBP-regulated metabolic pathways in vitro. Wang Q; Hu R; Li W; Tai Y; Gu W; Das BC; Yang F; Ji J; Wang C; Zhou J Mol Cell Endocrinol; 2021 Mar; 523():111135. PubMed ID: 33359761 [TBL] [Abstract][Full Text] [Related]
5. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma. Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360 [TBL] [Abstract][Full Text] [Related]
6. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth. Liu L; Yan H; Ruan M; Yang H; Wang L; Lei B; Sun X; Chang C; Huang G; Xie W Cancer Sci; 2021 Aug; 112(8):3083-3098. PubMed ID: 34033176 [TBL] [Abstract][Full Text] [Related]
7. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades. Shi Y; Fan Y; Hu Y; Jing J; Wang C; Wu Y; Geng Q; Dong X; Li E; Dong D J Cell Mol Med; 2020 Jan; 24(1):760-771. PubMed ID: 31762191 [TBL] [Abstract][Full Text] [Related]
8. Sterol regulatory element binding protein-1 (SREBP1) gene expression is similarly increased in polycystic ovary syndrome and endometrial cancer. Shafiee MN; Mongan N; Seedhouse C; Chapman C; Deen S; Abu J; Atiomo W Acta Obstet Gynecol Scand; 2017 May; 96(5):556-562. PubMed ID: 28176325 [TBL] [Abstract][Full Text] [Related]
9. The effect of feed restriction on expression of hepatic lipogenic genes in broiler chickens and the function of SREBP1. Wang PH; Ko YH; Chin HJ; Hsu C; Ding ST; Chen CY Comp Biochem Physiol B Biochem Mol Biol; 2009 Aug; 153(4):327-31. PubMed ID: 19383549 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of SREBP1 (sterol regulatory element binding protein 1) promotes de novo fatty acid synthesis and triacylglycerol accumulation in goat mammary epithelial cells. Xu HF; Luo J; Zhao WS; Yang YC; Tian HB; Shi HB; Bionaz M J Dairy Sci; 2016 Jan; 99(1):783-95. PubMed ID: 26601584 [TBL] [Abstract][Full Text] [Related]
11. DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis. Feng T; Li S; Zhao G; Li Q; Yuan H; Zhang J; Gu R; Ou D; Guo Y; Kou Q; Wang Q; Li K; Lin P Cell Oncol (Dordr); 2023 Oct; 46(5):1235-1252. PubMed ID: 37052853 [TBL] [Abstract][Full Text] [Related]
12. Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis. Meng H; Shen M; Li J; Zhang R; Li X; Zhao L; Huang G; Liu J Eur J Pharmacol; 2021 Sep; 906():174280. PubMed ID: 34174265 [TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma-Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element-Binding Protein 1 Activity to Promote Tumor Cell Proliferation and Growth. Wang C; Tong Y; Wen Y; Cai J; Guo H; Huang L; Xu M; Feng M; Chen X; Zhang J; Wu H; Kong X; Xia Q Hepatology; 2018 Nov; 68(5):1833-1850. PubMed ID: 29663480 [TBL] [Abstract][Full Text] [Related]
15. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation. Shi Z; Zhou Q; Gao S; Li W; Li X; Liu Z; Jin P; Jiang J Life Sci; 2019 Jan; 217():70-80. PubMed ID: 30452972 [TBL] [Abstract][Full Text] [Related]
16. SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism. Sun Y; He W; Luo M; Zhou Y; Chang G; Ren W; Wu K; Li X; Shen J; Zhao X; Hu Y Tumour Biol; 2015 Jun; 36(6):4133-41. PubMed ID: 25589463 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells. Li S; Oh YT; Yue P; Khuri FR; Sun SY Oncogene; 2016 Feb; 35(5):642-50. PubMed ID: 25893295 [TBL] [Abstract][Full Text] [Related]
18. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway. Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617 [TBL] [Abstract][Full Text] [Related]
19. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of SREBF chaperone (SCAP) enhances nuclear SREBP1 translocation to upregulate fatty acid synthase (FASN) gene expression in bovine mammary epithelial cells. Han LQ; Gao TY; Yang GY; Loor JJ J Dairy Sci; 2018 Jul; 101(7):6523-6531. PubMed ID: 29680640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]